Home » Authors » Anette Breindl

Articles by Anette Breindl

Activity Pattern Is More Affected Than Firing Level In Parkinson's

Oct. 25, 2006

By Anette Breindl

Activity Pattern Is More Affected Than Firing Level In Parkinson's

Oct. 25, 2006

By Anette Breindl

Enzyme Inhibitor Goes Past Diabetes To Sepsis, Cancer

Oct. 20, 2006

By Anette Breindl

Enzyme Inhibitor Goes Past Diabetes To Sepsis, Cancer

Oct. 20, 2006

By Anette Breindl

Peptide Anti-Infectives Increase Reach While Contracting Length

Oct. 19, 2006

By Anette Breindl

Peptide Anti-Infectives Increase Reach While Contracting Length

Oct. 19, 2006

By Anette Breindl

Unbiased Cell Cycle Work Reveals Surprise Players

Oct. 16, 2006

By Anette Breindl

Unbiased Cell Cycle Work Reveals Surprise Players

Oct. 16, 2006

By Anette Breindl

New Study Reveals Depths Of Ignorance On Cloning Basics

Oct. 13, 2006

By Anette Breindl

New Study Reveals Depths Of Ignorance On Cloning Basics

Oct. 13, 2006

By Anette Breindl

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 9, 2025
STAT6 stat sig? Kaken, J&J $1.2B-plus deal adds oomph to space
BioWorld
Kaken Pharmaceutical Co. Ltd.’s license agreement with Johnson & Johnson (J&J) for signal transducer and activator of transcription (STAT)6 inhibitor KP-723 could...
GLP-1 receptor agonists continue their global victory tour
BioWorld
2024 was another banner year for GLP-1 receptor agonists (GLP-1RAs) on multiple fronts. They continued to expand into new indications, and provide their...
AI drives financings, approvals for APAC med-tech in 2024
BioWorld MedTech
AI pulled in major financings and approvals for Asia med-techs in 2024 as Asia Pacific countries played to individual strengths to maximize AI’s applications in...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.